tiprankstipranks
Advertisement
Advertisement

PCGRINT Stock Latest News

GRIN Therapeutics Highlights Progress of Phase 3 Beeline Trial for GRIN-NDD
Private CompaniesGRIN Therapeutics Highlights Progress of Phase 3 Beeline Trial for GRIN-NDD
3h ago
GRINT
GRIN Therapeutics Emphasizes Patient Access and Support in Rare Disease Clinical Programs
PremiumPrivate Companies
GRIN Therapeutics Emphasizes Patient Access and Support in Rare Disease Clinical Programs
5d ago
GRINT
GRIN Therapeutics Highlights Patient Access and Support Strategy in Rare Neurodevelopmental Disorders
PremiumPrivate Companies
GRIN Therapeutics Highlights Patient Access and Support Strategy in Rare Neurodevelopmental Disorders
5d ago
GRINT
GRIN Therapeutics Highlights Focus on Autism and Rare Neurodevelopmental Conditions
PremiumPrivate Companies
GRIN Therapeutics Highlights Focus on Autism and Rare Neurodevelopmental Conditions
13d ago
GRINT
GRIN Therapeutics Emphasizes Broader Approach to Epilepsy and GRIN-Related Disorders
PremiumPrivate Companies
GRIN Therapeutics Emphasizes Broader Approach to Epilepsy and GRIN-Related Disorders
20d ago
GRINT
GRIN Therapeutics Emphasizes Broader Neurodevelopmental Focus Around Epilepsy Awareness
PremiumPrivate CompaniesGRIN Therapeutics Emphasizes Broader Neurodevelopmental Focus Around Epilepsy Awareness
20d ago
GRINT
GRIN Therapeutics Highlights Phase 3 Radiprodil Program and Angelini Pharma Partnership
Premium
Private Companies
GRIN Therapeutics Highlights Phase 3 Radiprodil Program and Angelini Pharma Partnership
29d ago
GRINT
GRIN Therapeutics Highlights Phase 3 Radiprodil Progress and Angelini Partnership
Premium
Private Companies
GRIN Therapeutics Highlights Phase 3 Radiprodil Progress and Angelini Partnership
29d ago
GRINT
GRIN Therapeutics Highlights Strategic Focus on GRIN2B-Related Neurodevelopmental Disorder
PremiumPrivate Companies
GRIN Therapeutics Highlights Strategic Focus on GRIN2B-Related Neurodevelopmental Disorder
30d ago
GRINT
GRIN Therapeutics Emphasizes GRIN2B-NDD Awareness and Patient Community Focus
PremiumPrivate Companies
GRIN Therapeutics Emphasizes GRIN2B-NDD Awareness and Patient Community Focus
1M ago
GRINT
Updated Pediatric Genetics Guidelines Highlight Growing Role of Early Testing in Rare Neurodevelopmental Disorders
PremiumPrivate Companies
Updated Pediatric Genetics Guidelines Highlight Growing Role of Early Testing in Rare Neurodevelopmental Disorders
1M ago
GRINT
GRIN Therapeutics Highlights Clinical Pipeline and Safety Focus in Neurodevelopmental Disorders
PremiumPrivate Companies
GRIN Therapeutics Highlights Clinical Pipeline and Safety Focus in Neurodevelopmental Disorders
1M ago
GRINT
GRIN Therapeutics Underscores Patient-Safety Focus in Ongoing Neurodevelopmental Trials
PremiumPrivate CompaniesGRIN Therapeutics Underscores Patient-Safety Focus in Ongoing Neurodevelopmental Trials
1M ago
GRINT
GRIN Therapeutics Emphasizes Focus on GRIN-Related Neurodevelopmental Disorders
Premium
Private Companies
GRIN Therapeutics Emphasizes Focus on GRIN-Related Neurodevelopmental Disorders
1M ago
GRINT
GRIN Therapeutics Emphasizes Commitment to GRIN-NDD Community During Awareness Month
Premium
Private Companies
GRIN Therapeutics Emphasizes Commitment to GRIN-NDD Community During Awareness Month
1M ago
GRINT
Workforce Diversity and Patient-Centric Culture Highlighted at GRIN Therapeutics
PremiumPrivate Companies
Workforce Diversity and Patient-Centric Culture Highlighted at GRIN Therapeutics
1M ago
GRINT
GRIN Therapeutics Highlights Role of Women in Research and Patient-Centered Culture
PremiumPrivate Companies
GRIN Therapeutics Highlights Role of Women in Research and Patient-Centered Culture
1M ago
GRINT
GRIN Therapeutics Emphasizes Focus on Neurodevelopmental and Rare Disorders
PremiumPrivate Companies
GRIN Therapeutics Emphasizes Focus on Neurodevelopmental and Rare Disorders
1M ago
GRINT
GRIN Therapeutics Emphasizes Focus on Rare Neurodevelopmental Disorders
PremiumPrivate Companies
GRIN Therapeutics Emphasizes Focus on Rare Neurodevelopmental Disorders
1M ago
GRINT
GRIN Therapeutics Highlights Focus on NMDA-Related Rare Neurological Disorders
PremiumPrivate CompaniesGRIN Therapeutics Highlights Focus on NMDA-Related Rare Neurological Disorders
2M ago
GRINT
Caregiver-Centric Focus Highlights GRIN Therapeutics’ Patient Engagement Strategy
Premium
Private Companies
Caregiver-Centric Focus Highlights GRIN Therapeutics’ Patient Engagement Strategy
2M ago
GRINT
Caregiver-Focused Approach Highlights GRIN Therapeutics’ Patient-Centric Strategy
Premium
Private Companies
Caregiver-Focused Approach Highlights GRIN Therapeutics’ Patient-Centric Strategy
2M ago
GRINT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >